Earnings
ASLN
3.220
+6.27%
0.190
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2020-12-31
14.32M
137.93K
--
--
--
--
528.84K
--
--
--
511.21K
--
15.50M
475.94K
--
0.00
--
--
160.00
--
103.31K
579.40K
16.08M
--
2.32M
0.00
--
--
--
--
--
4.14M
--
--
--
408.18K
10.66M
15.46M
--
--
--
111.99K
15.88M
26.23M
61.83M
123.58M
-195.68M
--
--
300.68K
-10.45M
-10.15M
16.08M
FY 2019-12-31
22.21M
--
--
--
--
--
0.00
--
--
--
68.94K
--
22.28M
766.53K
--
132.23K
--
--
2839.00
--
176.42K
1.08M
23.36M
--
1.87M
0.00
--
--
--
--
--
3.11M
--
--
--
137.21K
5.39M
18.13M
--
--
--
447.43K
19.65M
23.96M
63.44M
121.02M
-183.55M
--
--
1.07M
-1.68M
-603.54K
23.36M
FY 2019-12-31
22.20M
0.00
--
--
--
--
0.00
--
--
--
68.92K
--
22.27M
766.20K
--
200.42K
--
--
2850.00
--
108.08K
1.08M
23.35M
--
1.87M
0.00
--
--
--
--
--
3.11M
--
--
--
137.15K
5.38M
18.12M
--
--
--
447.22K
19.64M
23.95M
61.37M
116.50M
-179.48M
--
--
1.07M
-1.68M
-603.28K
23.35M
FY 2018-12-31
28.98M
--
--
0.00
--
--
0.00
--
--
--
184.07K
--
29.17M
289.13K
--
187.71K
--
--
23.14M
--
232.68K
23.85M
53.01M
--
5.33M
0.00
--
--
--
--
--
2.56M
--
--
--
129.76K
8.02M
14.01M
--
--
--
290.35K
14.30M
22.32M
52.56M
113.81M
-132.68M
--
--
--
30.70M
30.70M
53.01M
FY 2018-12-31
31.70M
--
--
0.00
--
--
0.00
--
--
--
201.36K
--
31.90M
316.28K
--
205.34K
--
--
25.31M
--
254.53K
26.09M
57.99M
--
5.83M
0.00
--
--
--
--
--
2.80M
--
--
--
141.94K
8.77M
15.33M
--
--
--
317.61K
15.64M
24.41M
57.50M
124.49M
-145.14M
--
--
--
33.58M
33.58M
57.99M

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out ASLN latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Aslan Pharms recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.